 |
Overview of the Israeli start up pharmaceutical industry
|
Nissim Darvish M.D., Ph.D.
Senior Managing Director, OrbiMed Israel
|
|
Quality and Regulatory aspects in early phase development of pharmaceutical products |
Rivka Zaibel
Founder, CEO and Consultant
ADRES, Advanced Regulatory Services Ltd.
|
|
The Israeli Healthtech Industry in the Era of Precision Medicine
|
Itai Kela, PhD, MBA
Senior Director, Healthcare & Biotechnology Sector Technology Division
Israel Innovation Authority |
|
Strategic Considerations for Manufacturing Process Development |
Oren Hershkovitz, Ph.D.
General Manager
OPKO Biologics Ltd. (f.k.a. Prolor-Biotech Ltd.) |
|
Preclinical and Toxicological aspects in early phase development of pharmaceutical products
|
Liat Hershkovitz, Ph.D
Director, Scientific and Regulatory Affairs
ADRES Advanced Regulatory Services Ltd. |
|
Developing your Process for future scale-up and commercial viability
|
Sarel Chen-Tov
CEO, Biopharmax Ltd |
|
Drug Development -
Points to Consider
The Regulator View
|
Dr. Ofra Axelrod
Director of The Institute for Standardization and Control of Pharmaceuticals, Israeli MOH |
